Neurology of systemic autoimmune disorders: A pediatric perspective

Seminars in Pediatric Neurology

Volumn 7, Issue 2, 2000, Pages 108-117

  Schor, Nina Felice ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADOLESCENT DISEASE; ARTICLE; AUTOIMMUNE DISEASE; BEHCET DISEASE; CHILD; CHILDHOOD DISEASE; DERMATOMYOSITIS; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; NEUROIMMUNOLOGY; NEUROLOGIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0033943020     PISSN: 10719091     EISSN: None     Source Type: Journal    
DOI: 10.1053/pb.2000.6692     Document Type: Article

References (115)

1. DeSilva TN Kress DW Management of collagen vascular diseases in childhood Pediatr Dermatol 16 1998 579 592
2. Matsumoto R Nakano I Shiga J Systemic lupus erythematosus with multiple perivascular spongy changes in the cerebral deep structures, midbrain and cerebellar white matter: A case report J Neurol Sci 145 1997 147 153
3. Gieron MA Khoromi S Campos A MRI changes in the central nervous system in a child with lupus erythematosus Pediatr Radiol 25 1995 184 185
4. Inslicht DV Stein AB Pomerantz F Three women with lupus transverse myelitis: case reports and differential diagnosis Arch Phys Med Rehabil 79 1998 456 459
5. Calabrese LV Stern TA Neuropsychiatric manifestations of systemic lupus erythematosus Psychosomatics 36 1995 344 359
6. Kashihara K Nakashima S Kohira I Hyperintense basal ganglia on T1-weighted MR images in a patient with central nervous system lupus and chorea AJNR Am J Neuroradiol 19 1998 284 286
7. Anzola GP Dalla Volta G Balestrieri G Headaches in patients with systemic lupus erythematosus: Clinical and telethermographic findings Arch Neurol 45 1988 1061 1062
8. Tincani A Brey R Balestrieri G International survey on the management of patients with SLE. II: The results of a questionnaire regarding neuropsychiatric manifestations Clin Exp Rheumatol 14 suppl 16 1996 S23 S29
9. Lin W-Y Wang S-J Yen T-C Technitium-99m-HMPAO brain SPECT in systemic lupus erythematosus with CNS involvement J Nucl Med 38 1997 1112 1115
10. Sibbitt WL Jr Haseler LJ Griffey RR Neurometabolism of active neuropsychiatric lupus determined with proton MR spectroscopy AJNR Am J Neuroradiol 18 1997 1271 1277
11. Glanz BI Slonim D Urowitz MB Pattern of neuropsychologic dysfunction in inactive systemic lupus erythematosus Neuropsychiatr Neuropsychol Behavioral Neurol 10 1997 232 238
12. Bombardier C Gladman DD Urowitz MB Derivation of the SLEDAI: A disease activity index for lupus patients Arthritis Rheum 35 1992 630 640
13. Kozora E West SG Kotzin BL Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease Arthritis Rheum 41 1998 41 47
14. Chinn RJS Wilkinson ID Hall-Craggs MA Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus Arthritis Rheum 40 1997 36 46
15. Gonzalez-Crespo MR Blanco FJ Ramos A Magnetic resonance imaging of the brain in systemic lupus erythematosus Br J Rheumatol 34 1995 1055 1060
16. Sibbitt WL Jr Brooks WM Haseler LJ Spin-spin relaxation of brain tissues in systemic lupus erythematosus: A method for increasing the sensitivity of magnetic resonance imaging for neuropsychiatric lupus Arthritis Rheum 38 1995 810 818
17. Provenzale JM Barboriak DP Allen NB Patients with antiphospholipid antibodies: CT and MR findings of the brain AJR Am J Roentgenology 167 1996 1573 1578
18. Ellis SG Verity MA Central nervous system involvement in systemic lupus erythematosus: A review of neuropathologic findings in 57 cases, 1955–1977 Semin Arthritis Rheum 8 1979 212 221
19. Liem MD Gzesh DJ Flanders AE MRI and angiographic diagnosis of lupus cerebral vasculitis Neuroradiology 38 1996 134 136
20. Tanabe J Weiner MW MRI-MRS of the brain in systemic lupus erythematosus: How do we use it to understand causes of clinical signs? Ann NY Acad Sci 823 1997 169 184
21. Welch KMA Nagesh V Boska M Detection of cerebral ischemia in systemic lupus erythematosus by magnetic resonance techniques Ann NY Acad Sci 823 1997 120 131
22. Griffey RH Brown MS Bankhurst AD Depletion of high-energy phosphates in the central nervous system of patients with systemic lupus erythematosus, as determined by phosphorus-31 nuclear magnetic resonance spectroscopy Arthritis Rheum 33 1990 827 833
23. Sailer M Burchert W Ehrenheim C Positron emission tomography and magnetic resonance imaging for cerebral involvement in patients with systemic lupus erythematosus J Neurol 244 1997 186 193
24. Huang J-L Yeh K-W You D-L Serial single photon emission computed tomography imaging in patients with cerebral lupus during acute exacerbation and after treatment Pediatr Neurol 17 1997 44 48
25. Otte A Weiner SM Peter HH Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: A controlled positron emission tomography study Eur J Nucl Med 24 1997 787 791
26. 99mTc-HMPAO SPET in systemic lupus erythematosus Eur J Nucl Med 22 1995 1073 1077
27. 99mTc-HMPAO in neuropsychiatric systemic lupus erythematosus: Relations with EEG and MRI findings and clinical manifestations Eur J Nucl Med 22 1995 17 24
28. Colamussi P Trotta F Ricci R Brain perfusion SPET and proton magnetic resonance imaging spectroscopy in the evaluation of two systemic lupus erythematosus patients with mild neuropsychiatric manifestations Nucl Med Comm 18 1997 269 273
29. Kovacs JA Urowitz MB Gladman DD The use of single photon emission computerized tomography in neuropsychiatric SLE: A pilot study J Rheumatol 22 1995 1247 1253
30. Crimando J Hoffman SA Detection of brain reactive autoantibody in sera of autoimmune mice using ELISA J Immunol Methods 149 1992 87 95
31. Ochola J Hussain M Khamashta M Detection of brain-reactive autoantibodies in the sera of patients with systemic lupus erythematosus and cerebral involvement J Immunol Methods 185 1995 259 261
32. McLean BN Miller D Thompson EJ Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Behçet's disease involving the nervous system J Neurol Neurosurg Psychiatry 58 1995 548 554
33. West SG Woodruff E Wener MH Neuropsychiatric lupus erythematosus: A 10-year prospective study on the value of diagnostic tests Am J Med 99 1995 153 163
34. Moore PM Vo T Carlock LR Identification and cloning of a brain autoantigen in neuro-behavioral SLE J Neuroimmunol 82 1998 116 125
35. Kelley KW Hutchinson K French R Central interleukin-1 receptors as mediators of sickness Ann NY Acad Sci USA 823 1997 234 246
36. Medsger TA Jr Dawson WN Masi AT The epidemiology of polymyositis Am J Med 48 1970 715 723
37. Oddis CV Conte CG Steen VD Incidence of polymyositis-dermatomyositis: A 20 year study of hospital diagnosed cases in Allegheny County, PA, 1963–82 J Rheumatol 17 1990 1329 1334
38. Benbassat J Geffel D Zlotnick A Epidemiology of polymyositis-dermatomyositis in Israel, 1960–76 Isr J Med Sci 16 1980 197 200
39. Symmons DPM Sills JA Davis SM The incidence of juvenile dermatomyositis: Results from a nation-wide study Br J Rheumatol 34 1995 732 736
40. Pachman LM Hayford JR Chung A Juvenile dermatomyositis at diagnosis: Clinical characteristics of 79 children J Rheumatol 25 1998 1198 1204
41. Pachman LM An update on juvenile dermatomyositis Curr Opin Rheumatol 7 1995 437 441
42. Huang J-L Juvenile dermatomyositis associated with partial lipodystrophy Br J Clin Pract 50 1996 112 113
43. See Y Rooney M Woo P Palmar plantar hyperkeratosis-a previously undescribed skin manifestation of juvenile dermatomyositis Br J Rheumatol 36 1997 917 919
44. Eisenstein DM Paller AS Pachman LM Juvenile dermatomyositis presenting with rash alone Pediatrics 100 1997 391 392
45. Kagen LJ Amyopathic dermatomyositis Arch Dermatol 131 1995 1458 1459
46. Hess Schmid MH Trüeb RM Juvenile amyopathic dermatomyositis Br J Dermatol 136 1997 431 433
47. Vogelgesang SA Gutierrez J Klipple GL Polyneuropathy in juvenile dermatomyositis J Rheumatol 22 1995 1369 1372
48. Falcini F Trapani S Ermini M Systemic vasculitis in juvenile dermatomyositis: A fatal case Clin Exp Rheumatol 13 1995 531 532
49. Stoll T Brühlmann P Stucki G Muscle strength assessment in polymyositis and dermatomyositis evaluation of the reliability and clinical use of a new, quantitative, easily applicable method J Rheumatol 22 1995 473 477
50. King LE Jr Park JH Adams LB Phosphorus 31 magnetic resonance spectroscopy for quantitative evaluation of therapeutic regimens in dermatomyositis Arch Dermatol 131 1995 522 524
51. Amato AA Barohn RJ Idiopathic inflammatory myopathies Neurol Clin 15 1997 615 648
52. Jongen PJH Vingerhoets HM Roeleveld K Automatic decomposition electromyography in idiopathic inflammatory myopathies J Neurol 243 1996 79 85
53. Olsen NJ Park JH Inflammatory myopathies: Issues in diagnosis and management Arthritis Care and Research 10 1997 200 207
54. Olsen NJ Park JH MRS and NIRS for muscle disease evaluation Bull Rheum Dis 44 1995 4 7
55. Lofberg M Liewendahl K Lamminen A Antimyosin scintigraphy compared with magnetic resonance imaging in inflammatory myopathies Arch Neurol 55 1998 987 993
56. Feldman BM Ayling-Campos A Luy L Measuring disability in juvenile dermatomyositis: validity of the childhood health assessment questionnaire J Rheumatol 22 1995 326 331
57. Bloom BJ Tucker LB Miller LC Von Willebrand Factor in juvenile dermatomyositis J Rheumatol 22 1995 320 325
58. Pachman LM Imperfect indications of disease activity in juvenile dermatomyositis J Rheumatol 22 1995 193 197
59. Mokuno K Kiyosawa K Honda H Elevated serum levels of manganese superoxide dismutase in polymyositis and dermatomyositis Neurology 46 1996 1445 1447
60. Nishikai M Ohya K Kosaka M Anti-Jo-1 antibodies in polymyositis or dermatomyositis: Evaluation by ELISA using recombinant fusion protein Jo-1 as antigen Br J Dermatol 37 1998 357 361
61. Feldman BM Reichlin M Laxer RM Clinical significance of specific autoantibodies in juvenile dermatomyositis J Rheumatol 23 1996 1794 1797
62. Roux S Seelig HP Meyer O Significance of Mi-2 autoantibodies in polymyositis and dermatomyositis J Rheumatol 25 1998 395 396
63. Vazquez-Abad D Rothfield NF Sensitivity and specificity of anti-Jo-1 antibodies in autoimmune diseases with myositis Arthritis Rheum 39 1996 292 296
64. Hirakata M Suwa A Takeda Y Autoantibodies to glycyl-transfer RNA synthetase in myositis: Association with dermatomyositis and immunologic heterogeneity Arthritis Rheum 39 1996 146 151
65. Nilasena DS Trieu EP Targoff IN Analysis of the Mi-2 autoantigen of dermatomyositis Arthritis Rheum 38 1995 123 128
66. Seelig HP Moosbrugger I Ehrfeld H The major dermatomyositis-specific Mi-2 autoantigen is a presumed helicase involved in transcriptional activation Arthritis Rheum 38 1995 1389 1399
67. Seelig HP Renz M Targoff IN Two forms of the major antigenic protein of the dermatomyositis-specific Mi-2 autoantigen Arthritis Rheum 39 1996 1769 1771
68. Ge Q Nilasena DS O'Brien CA Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen J Clin Invest 96 1995 1730 1737
69. *0501 allele in multiple racial groups with juvenile dermatomyositis Hum Immunol 44 1995 131 135
70. Reed AM Pachman LM Hayford J Immunogenetic studies in families of children with juvenile dermatomyositis J Rheumatol 25 1998 1000 1002
71. Furuya T Hakoda M Higami K Association of HLA class I and class II alleles with myositis in Japanese patients J Rheumatol 25 1998 1109 1114
72. Buderus S Wagner N Lentze MJ Concurrence of celiac disease and juvenile dermatomyositis: Result of a specific immunogenetic susceptibility? J Pediatr Gastroenterol Nutr 25 1997 101 103
73. *0301 molecule J Immunol 159 1997 6260 6265
74. Dalakas MC Sivakumar K The immunopathologic and inflammatory differences between dermatomyositis, polymyositis and sporadic inclusion body myositis Curr Opin Neurol 9 1996 235 239
75. Basta M Illa I Dalakas MC Increased in vitro uptake of the complement C3b in the serum of patients with Guillain-Barré syndrome, myasthenia gravis and dermatomyositis J Neuroimmunol 71 1997 227 229
76. Mendell JR Garcha TS Kissel JT The immunopathogenic role of complement in human muscle disease Curr Opin Neurol 9 1996 226 234
77. Schneider C Gold R Dalakas MC MHC class I-mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory T cells: Studies in patients with polymyositis, dermatomyositis, and inclusion body myositis J Neuropathol Exp Neurol 55 1996 1205 1209
78. Tews DS Goebel HH Cell death and oxidative damage in inflammatory myopathies Clin Immunol Immunopathol 87 1998 240 247
79. Behrens L Bender A Johnson MA Cytotoxic mechanisms in inflammatory myopathies: Co-expression of Fas and protective Bcl-2 in muscle fibres and inflammatory cells Brain 120 1997 929 938
80. Schor NF Whimpers and bangs: of death and dying in the nervous system J Child Neurol 13 1998 307 312
81. Mastaglia FL Phillips BA Zilko P Treatment of inflammatory myopathies Muscle Nerve 20 1997 651 664
82. Ng Y-T Ouvrier RA Wu T Drug therapy in juvenile dermatomyositis: Follow-up study J Child Neurol 13 1998 109 112
83. Lang B Dooley J Failure of pulse intravenous methylprednisone treatment in juvenile dermatomyositis J Pediatr 128 1996 429 432
84. Cherin P Auperin I Bussel Plasma exchange in polymyositis and dermatomyositis: A multi center study of 57 cases Clin Exp Rheumatol 13 1995 270 271
85. Vedanarayanan V Subramony SH Ray LI Treatment of childhood dermatomyositis with high dose intravenous immunoglobulin Pediatr Neurol 13 1995 336 339
86. Dalakas MC Update on the use intravenous immune globulin in the treatment of patients with inflammatory muscle disease J Clin Immunol 15 1995 70S 75S
87. Sansome A Dubowitz V Intravenous immunoglobulin in juvenile dermatomyositis-four year review of nine cases Arch Dis Child 72 1995 25 28
88. Mastaglia FL Philips BA Zilko PJ Immunoglobulin therapy in inflammatory myopathies J Neurol Neurosurg Psychiatry 65 1998 107 110
89. Galeazzi M Bellucci AM Girardelli CR Efficacy of intravenous immunoglobulin therapy in a case of juvenile dermatomyositis Clin Rheumatol 15 1996 215 216
90. Oliveri MB Palermo R Mautalen C Regression of calcinosis during diltiazem treatment in juvenile dermatomyositis J Rheumatol 23 1996 2152 2155
91. Eddy MC Leelawattana R McAlister WH Calcinosis universalis complicating juvenile dermatomyositis: Resolution during probenecid therapy J Clin Endocrinol Metab 82 1997 3536 3542
92. Wiesinger GF Quittan M Aringer M Improvement of physical fitness and muscle strength in polymyositis/dermatomyositis patients by a training programme Br J Rheumatol 37 1998 196 200
93. Collison CH Sinal SH Jorizzo JL Juvenile dermatomyositis and polymyositis: A follow-up study of long-term sequelae South Med J 91 1998 17 22
94. Salih AM Nixon RM Heath P Anti-ganglioside antibodies in patients with rheumatoid arthritis complicated by peripheral neuropathy Br J Rheumatol 35 1996 725 731
95. Bekkelund SI Mellgren SI Proven A Quantified neurological examination with emphasis on motor and sensory functions in patients with rheumatoid arthritis and controls Br J Rheumatol 35 1996 1116 1121
96. Kaye O Beckers CC Paquet P The frequency of cutaneous vasculitis is not increased in patients with rheumatoid arthritis treated with methotrexate J Rheumatol 23 1996 253 257
97. Evans OB Polyneuropathy in childhood Pediatrics 64 1979 96 105
98. Puusa A Lang HA Makel A-L Nerve conduction velocities in juvenile rheumatoid arthritis Acta Neurol Scand 73 1986 145 150
99. Farah S Al-Shubaili A Montaser A Behcet's syndrome: A report of 41 patients with emphasis on neurological manifestations J Neurol Neurosurg Psychiatry 64 1998 382 384
100. Serdaroglu P Behcet's disease and the nervous system J Neurol 245 1998 197 205
101. Uziel Y Brik R Padeh S Juvenile Behcet's disease in Israel: The Pediatric Rheumatology Study Group of Israel Clin Exper Rheumatol 16 1998 502 525
102. Eldem B Onur C Ozen S Clinical features of pediatric Behcet's disease J Pediat Ophthal Strabis 35 1998 159 161
103. Oktem-Tanor O Baykan-Kurt B Gurvit IH Neuropsychological follow-up of 12 patients with neuro-Behcet disease J Neurol 246 1999 113 119
104. Bogdanova D Milanov I Georgiev D Parkinsonian syndrome as a neurological manifestation of Behcet's disease Can J Neurol Sci 25 1998 82 85
105. Cetinel B Akpinar H Tufek I Bladder involvement in Behcet's syndrome J Urol 161 1999 52 56
106. Kazarians H Voelter HU Schwendemann G Muscular necrotizing vasculitis as the initial manifestation of Behcet's disease Muscle Nerve 22 1999 430 431
107. Kao CH Lan JL Chang Lai SP Technicium-99m-HMPAO SPECT and MRI of brain in patients with neuro-Behcet's syndrome J Nucl Med 39 1998 1707 1710
108. Garcia-Burillo A Castell J Fraile M Technicium-99m-HMPAO brain SPECT in Behcet's disease J Nucl Med 39 1998 950 954
109. Mirone L Altomonte L Raco A Cerebral bloodflow abnormalities detected by SPECT in Behcet's syndrome-related psychiatric disorders Clin Rheumatol 17 1998 75 76
110. Hirohata S Suda H Hashimoto T Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behcet's disease J Neurol Sci 159 1998 181 185
111. Tasci B Direskeneli H Serdaroglu P Humoral immune response to mycobacterial heat shock protein (hsp)65 in the cerebrospinal fluid of neuro-Behcet patients Clin Exp Immunol 113 1998 100 104
112. Lenk N Ozet G Alli N Protien C and protein S activities in Behcet's disease as risk factors of thrombosis Int J Dermatol 37 1998 124 125
113. Alexander EL Provost TT Stevens MB Neurologic complications of primary Sjogren's syndrome Medicine 61 1982 247 257
114. Moore PM Fauci AS Neurologic manifestations of systemic vasculitis: A retrospective and prospective study of the clinicopathologic features and responses to therapy in 25 patients Am J Med 71 1981 517 524
115. Singhal BS Khadilkar SV Gursahani RD Vasculitic neuropathy: Profile of twenty patients J Assoc Physicians India 43 1995 459 461